c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Oppenheimer reiterates Outperform on UroGen Pharma stock at $60
Investing.com | Nov 5, 2026 6:14 AM EST
Read original article